Mhatre R M, Green D, Panasci L C, Woolley P V, Schein P S
Cancer Treat Rep. 1978 Aug;62(8):1145-51.
Cholorozotocin is a water-soluble chloroethylnitrosourea with the cytotoxic group attached to the C2 position of glucose. The distribution of the alkylating and carbamoylating moieties of the chlorozotocin molecule was determined in mice following the ip administration of an LD10 dose: 20 mg/kg. The half-life (T 0.5) for the plasma disappearance of intact drug was 5 minutes. The plasma disappearance of the ethyl-14C group was biphasic up to 120 minutes after administration; the T 0.5 of the initial phase was 17.5 minutes and the T 0.5 of the prolonged second phase was107 minutes. The disappearance of glucose-14C chlorozotocin followed kinetics similar to the chloroethyl-labeled compound. Fifteen minutes after administration, ethyl-14C drug concentrated maximally in the liver (194 nmols/g of tissue) and the kidney (131 nmols/g of tissue). Uptake into the bone marrow at 60 minutes after ip administration of the ethyl-labeled drug was 6.6 pmols of the ethyl-14C group covalently bound to proteins and nucleic acids per 10(7) nucleated cells. The concentration of ethyl-14C drug in the brain remained at 4 mnols/g of tissue up to 2 hours after administration, reflecting the water-soluble property of this new nitrosourea.
氯脲霉素是一种水溶性氯乙基亚硝基脲,其细胞毒性基团连接在葡萄糖的C2位。在腹腔注射LD10剂量(20mg/kg)后,测定了氯脲霉素分子中烷基化和氨甲酰化部分在小鼠体内的分布。完整药物在血浆中消失的半衰期(T0.5)为5分钟。给药后120分钟内,乙基-14C基团在血浆中的消失呈双相性;初始阶段的T0.5为17.5分钟,延长的第二阶段的T0.5为107分钟。葡萄糖-14C氯脲霉素的消失动力学与氯乙基标记化合物相似。给药后15分钟,乙基-14C药物在肝脏(194nmol/g组织)和肾脏(131nmol/g组织)中浓度最高。腹腔注射乙基标记药物60分钟后,骨髓中摄取量为每10(7)个有核细胞6.6pmol与蛋白质和核酸共价结合的乙基-14C基团。给药后2小时内,脑中乙基-14C药物浓度维持在4nmol/g组织,反映了这种新亚硝基脲的水溶性。